CAS: 1132709-15-9 - B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid

Fórmula: C₁₉H₂₅BN₄O₄

InChI: InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17+/m1/s1

Chave InChI: InChIKey=GXJABQQUPOEUTA-WBVHZDCISA-N

SMILES: O=C(NC(C(=O)NC(B(O)O)CC(C)C)CC=1C=CC=CC1)C2=NC=CN=C2

((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid

CAS: 1132709-15-9

• Fórmula: C₁₉H₂₅BN₄O₄
• Cor e Forma: Solid
• Peso molecular: 384.2372

(1R,2R)-Bortezomib

CAS: 1132709-15-9

• Fórmula: C₁₉H₂₅BN₄O₄
• Cor e Forma: White To Off-White Solid
• Peso molecular: 384.24

(1R,2R)-Bortezomib

CAS: 1132709-15-9

Impurity Bortezomib USP Related Compound A Applications (1R,2R)-Bortezomib is a diastereomer of Bortezomib (B675700), the …

• Fórmula: C₁₉H₂₅BN₄O₄
• Pureza: >85%
• Cor e Forma: Neat
• Peso molecular: 384.24

(1R,2R)-Bortezomib-d5

CAS: 1132709-15-9

Please enquire for more information about (1R,2R)-Bortezomib-d5 including the price, delivery time and more detailed …

• Fórmula: C₁₉H₂₀D₅BN₄O₄
• Pureza: Min. 95%
• Peso molecular: 389.27 g/mol